Related Experiment Videos
Treatment of Goodpasture's syndrome with immunosuppression and plasmapheresis
Southern Medical Journal
|October 1, 1979
Insights
Goodpasture's syndrome in a boy rapidly improved with treatment. Doctors used prednisone, cyclophosphamide, and plasmapheresis to remove anti-glomerular basement membrane antibodies, stabilizing kidney function.
Area of Science:
- Nephrology
- Immunology
- Pediatric Medicine
Background:
- Goodpasture's syndrome is a rare autoimmune disorder characterized by antibodies targeting the glomerular basement membrane.
- It primarily affects the kidneys and lungs, leading to rapid decline in renal function and potentially respiratory failure.
Observation:
- A 14-year-old male presented with Goodpasture's syndrome, marked by decreasing kidney function.
- Serum levels of anti-glomerular basement membrane (anti-GBM) antibodies were progressively increasing in the patient.
Findings:
- Combined treatment with prednisone, cyclophosphamide, and plasmapheresis led to a swift reduction in serum anti-GBM antibody levels.
- This therapeutic intervention resulted in the temporary stabilization of the patient's renal function.
Implications:
- This case highlights the efficacy of a multi-modal treatment approach for anti-GBM antibody disease in pediatric patients.
- Early and aggressive intervention may be crucial for managing Goodpasture's syndrome and preserving kidney function.
Abstract:
A 14-year-old boy with Goodpasture's syndrome induced by anti-glomerular-basement-membrane (gmb) antibody exhibited declining renal function, in association with a progressive increase in the level of serum anti-GBM antibody. Treatment with prednisone, cyclophosphamide, and plasmapheresis was associated with rapid disappearance of the serum anti-GMB antibody and temporary stabilization of renal function.